Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding XBiotech Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of XBIT: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders48341−4
Shares2.94M23.9K2.30M−616.4K (−21.2%)
Value$7.81M$63.7K$5.48M−$2.26M (−29.2%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held XBiotech Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to XBIT in Q4 2025
InstitutionSharesValue% of portfolio
Ameriprise Financial Inc186,796$446.4K0.00%
Persistent Asset Partners Ltd13,565$32.4K0.02%
Pinnacle Financial Partners, Inc.11,796$28.2K0.00%
Two Sigma Securities, LLC10,378$24.8K0.00%

Sold out (8)

Institutions that held XBiotech Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of XBIT in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Citadel Advisors LLC42,816$113.9K
HRT Financial LP26,156$69.0K
SRS Capital Advisors, Inc.22$58
EverSource Wealth Advisors, LLC17$45
Essential Partners LLC16$43
Citigroup Inc12$32
True Wealth Design, LLC3$8
Sunbelt Securities, Inc.2$5

Not filed for Q4 2025 yet (3)

Institutions that held XBiotech Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XBIT in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Synovus Financial Corp11,796$31.4K
Point72 Asia (Singapore) Pte. Ltd.6,817$18.1K
Cubist Systematic Strategies, LLC5,320$14.2K